Alkermes (ALKS) Tops Q3 EPS by 8c

Alkermes (NASDAQ: ALKS) reported Q3 EPS of $0.14, $0.08 better than the analyst estimate of $0.06. Revenue for the quarter came in at $294.1 million versus the consensus estimate of $301.59 million.

For earnings history and earnings-related data on Alkermes (ALKS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c